I undersøgelsen af patienter, der fik mindre emetogen kemoterapibehandling, var procentandelen 50, 8% (EMEND- gruppen) og 42, 5% (sammenligningsgruppen).
In the study in patients receiving less emetogenic chemotherapy, the percentages were 50.8% (EMEND group) and 42.5% (comparator group).